The study included 374 women with benign endometrium findings, 256 with endometrial cancer, 37 with atypical hyperplasia, and 29 with benign hyperplasia. The majority of cancers were grade 1 ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

The addition of glucagon-like peptide-1 receptor agonists to progestin therapy may help reduce endometrial cancer risk among certain women, according to study results. Findings presented at ...